AG
AMED

Advisor Group’s Amedisys AMED Stock Holding History

Advisor Group’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$1.44M Buy
8,626
+5,896
+216% +$877K 0.01% 986
2019
Q3 		$359K Sell
2,730
-1,071
-28% -$139K ﹤0.01% 1859
2019
Q2 		$462K Buy
3,801
+2,216
+140% +$263K ﹤0.01% 1673
2019
Q1 		$195K Buy
1,585
+223
+16% +$28K ﹤0.01% 2300
2018
Q4 		$160K Sell
1,362
-1,864
-58% -$220K ﹤0.01% 2263
2018
Q3 		$403K Buy
3,226
+1,270
+65% +$140K ﹤0.01% 1628
2018
Q2 		$167K Buy
1,956
+707
+57% +$51.9K ﹤0.01% 2117
2018
Q1 		$76K Buy
1,249
+500
+67% +$28.5K ﹤0.01% 2769
2017
Q4 		$39K Sell
749
-636
-46% -$33.5K ﹤0.01% 3252
2017
Q3 		$77K Buy
1,385
+1,100
+386% +$58.2K ﹤0.01% 2626
2017
Q2 		$18K Buy
285
+245
+613% +$14.3K ﹤0.01% 3548
2017
Q1 		$2K Hold
40
– – ﹤0.01% 4360
2016
Q4 		$2K Hold
40
– – ﹤0.01% 4192
2016
Q3 		$2K Sell
40
-1,107
-97% -$55.2K ﹤0.01% 4137
2016
Q2 		$57K Buy
+1,147
New +$57.9K ﹤0.01% 2327

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $96.1B AUM 40.06% 1-Year Est. Return

Advisor Group's AMED Position: Q4 2019 in Review

Advisor Group increased its Amedisys (AMED) stake by 216% in Q4 2019, buying an estimated $877K and bringing the position to 8,626 shares worth $1.44M. The position accounts for 0.01% of the portfolio, ranked #986.

Advisor Group first reported a position in AMED in Q2 2016 and has held it in 15 quarters since. 325 funds tracked by Wall St. Rank hold AMED as of Q4 2019.

  • Advisor Group held 8,626 shares of Amedisys worth $1.44M as of Q4 2019.
  • Advisor Group bought 5,896 Amedisys shares in Q4 2019, an estimated $877K.
  • Amedisys made up 0.01% of Advisor Group's portfolio in Q4 2019, its #986 holding.
  • Advisor Group first reported a position in Amedisys in Q2 2016 and has held it in 15 quarters since.
  • 325 funds tracked by Wall St. Rank held Amedisys as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.